Vincent Chung, Katherine A. Guthrie, Michael J. Pishvaian, Andrew M. Lowy, Davendra Sohal, Kim Anna Reiss, Nina Niu Sanford, Carmen Allegra, Sarah Colby, Eileen M. O'Reilly, E. Gabriela Chiorean, Philip Agop Philip. "Randomized phase II trial of olaparib + pembrolizumab vs olaparib alone as maintenance therapy in patients with metastatic pancreatic cancer with germline BRCA1 or BRCA2 mutations: SWOG S2001 NCT04548752.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.4_suppl.tps793